Presented by Per Liden, General Manager, GoSilico at Cytiva.
Simulation for in silico process development is becoming a viable option to reduce the time needed for chemicals, manufacturing, and control (CMC) activities and increase process understanding. Advances in analytics and modeling — and their application to biopharmaceutical products — are driving efforts to transform process development.
In this session, you’ll gain insight on how to apply simulation in your CMC activities, including case studies of the successful use of simulation in biopharmaceutical process development.
